Analyte Derivatization and Extraction for Low-Level LC-MS/MS Quantification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting catecholamines and other analytes are cumbersome, unstable, and lack sensitivity, leading to unreliable results and high lower limits of quantification, particularly in clinical and forensic applications.
Innovation Solution
A method combining solid phase extraction with chemical derivatization using Fmoc chloride and LC-MS/MS for sensitive and accurate detection of analytes such as catecholamines, metanephrines, and thyroid hormones, allowing for analyte-specific, stable, and robust measurements at low concentrations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional extraction procedures are used for catecholamine quantification, then the process is established and reproducible, but the results are unreliable with high lower limits of quantification (>10ng/mL) and poor stability
Solution Approach 1:
The patent changes the chemical parameters of the analytes by performing derivatization reactions. Catecholamines are derivatized with reagents such as dansyl chloride, fluorogenic reagents, or other chemical modifiers that change their physical and chemical properties. This transformation increases their detectability by mass spectrometry, lowering the LLOQ from >10ng/mL to pg/mL range and improving measurement precision while maintaining reliability
Solution Approach 2:
The patent introduces derivatization reagents as intermediary substances that react with catecholamines to form derivative compounds. These intermediaries (derivatization reagents) enable better extraction efficiency and detection sensitivity. The derivatives have improved stability and detectability compared to native catecholamines, resolving the contradiction between reliability and measurement precision
2Reliability
If complex extraction procedures are used, then analyte recovery is achieved, but the process becomes cumbersome and unstable
Solution Approach 1:
The patent combines multiple steps into a streamlined process. The derivatization step is integrated with the extraction process, and the patent provides a unified method that achieves both analyte recovery and procedural simplicity. By combining extraction and derivatization into a coordinated protocol with optimized conditions, the patent reduces procedural complexity while maintaining stable analyte recovery
Solution Approach 2:
The patent optimizes extraction parameters such as pH, solvent composition, and temperature to achieve stable analyte recovery with simpler procedures. By adjusting these parameters in conjunction with derivatization, the patent reduces the need for complex multi-step procedures while maintaining reliable recovery
3Productivity
If automated detection methods are implemented, then speed and sensitivity are improved, but the requirement for stable sample preparation increases
Solution Approach 1:
The patent performs derivatization as a preliminary action before automated LC-MS/MS detection. By derivatizing catecholamines in advance with stable reagents and conditions, the patent ensures sample stability is established before the fast automated detection phase. This preliminary derivatization creates stable derivatives that can withstand automated processing while maintaining integrity through detection
Solution Approach 2:
The patent optimizes derivatization parameters (pH, temperature, reaction time, reagent concentration) to create stable derivatives that are compatible with automated detection systems. The derivatized products have improved stability compared to native catecholamines, enabling both fast automated analysis and reliable sample composition throughout the detection process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables sensitive and accurate measurements of analytes at low picogram per milliliter levels with small sample sizes, providing fast, automated, and reliable results without analyte crossovers, suitable for clinical and forensic settings.
Implementation Method 1
The analyte is extracted from the sample by a solid phase extraction
Implementation Method 2
chemical derivatization of the analyte
Data Source
Figure 1A
Figure 1B
Figure 2A
AI summary
The present specification discloses methods for determining the presence one or more analytes in a test sample, materials useful to perform the disclosed methods, and kits comprising reagents useful to practice the disclosed methods.